Hypofractionated Radiation Versus Conventional Fractionated Radiation: A Network Analysis.

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy Research

Background:

• Conventional fractionation (CF) and hypofractionation (HF) are radiotherapy techniques used in cancer treatment.
• Understanding the molecular mechanisms and comparative efficacy of CF and HF is crucial for optimizing cancer therapy.
• Proteomic analysis offers insights into cellular responses to different radiation fractionation schemes.

Purpose of the Study:

• To analyze proteomic findings from prostate cancer (PCa) cell line DU145 treated with CF and HF radiotherapy.
• To identify differentially expressed proteins (DEPs) and construct protein-protein interaction (PPI) networks.
• To determine common and discriminating protein hubs between CF and HF treatment groups.

Main Methods:

• Extraction of significant DEPs in DU145 cells exposed to CF and HF radiation from existing literature.
• Construction of PPI networks using the STRING database and Cytoscape software.
• Network analysis with "NetworkAnalyzer" to identify key protein hubs.

Main Results:

• 126 DEPs for CF and 63 DEPs for HF treatment were identified.
• Common hub proteins (e.g., ALB, CD44, THBS1) and discriminator hubs (e.g., VTM, OCLN, HSPB1) were identified.
• 70% of identified protein hubs were common to both CF and HF, suggesting shared radio-resistance mechanisms.

Conclusions:

• Both CF and HF radiotherapy induce radio-resistance in surviving prostate cancer cells.
• Specific protein hubs discriminate the cellular responses to CF versus HF.
• DU145 cells treated with CF appear to exhibit higher radio-resistance compared to those treated with hypofractionation.